Foundation Fighting Blindness selects Guardion’s VectorVision CSV-1000 Diagnostic Instrument for Use in Large-Scale Multi-Center Clinical Trial
Guardion Health Sciences, Inc. (GHSI)
Company Research
Source: GlobeNewswire
The CSV-1000 Diagnostic Instrument is Considered the Standard of Care for the Measurement of Contrast Sensitivity San Diego, CA, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), announced that its standardized vision testing instrument, the CSV-1000, has been selected by the Foundation Fighting Blindness for inclusion in a large-scale multi-center long-term clinical trial, the PRO-EYS Study. This study is being conducted to evaluate vision loss and progression in patients with degenerative retinal disease. There are expected to be about 30 sites in the study, with each site having a dedicated CSV-1000 device. The CSV-1000 is manufactured by Guardion’s VectorVision subsidiary. The mission of the Foundation Fighting Blindness is to fund research that will lead to the prevention, treatment and cure for the entire spectrum of retinal degenerative diseases. The Foundation Fighting Blindness is the largest-non-governmental so
Show less
Read more
Impact Snapshot
Event Time:
GHSI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GHSI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GHSI alerts
High impacting Guardion Health Sciences, Inc. news events
Weekly update
A roundup of the hottest topics
GHSI
News
- Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching [Yahoo! Finance]Yahoo! Finance
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023 [Yahoo! Finance]Yahoo! Finance
- Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2023GlobeNewswire
- Guardion Health Sciences, Inc. (NASDAQ: GHSI) had its "hold" rating re-affirmed by analysts at Maxim Group.MarketBeat
- Thinking about buying stock in Guardion Health Sciences, Minim, Revelation Biosciences, Nyxoah, or Pixelworks?PR Newswire
GHSI
Sec Filings
- 4/9/24 - Form 8-K
- 4/8/24 - Form DEFM14A
- 4/3/24 - Form 3
- GHSI's page on the SEC website